Financial report interval: 2025.12.31 - 2026.03.31
Overview: Longshenrongfa Pharmaceutical Industry(300534) the Revenue is 231.59 M (-15.69%);the EBIT is 35.91 M (-19.58%);the EPS is 0.0813 (+28.23%).